Kaneka Eurogentec
Seraing, BE
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-29
80.3
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: Kaneka Eurogentec
- Signal Score
- 80.3/100 (as of 2026-04-29)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Seraing, BE
- Modalities
- mRNA, Plasmid, Oligonucleotide
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Kaneka Eurogentec
European mRNA/pDNA CDMO with GMP capabilities.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Plasmid, Oligonucleotide
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Kaneka Corporation (4118.T)
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Kaneka Corporation (4118.T)
Financial assessment: 68.0/100
Capacity
58.0
1 manufacturing site: Seraing, Belgium
Modalities: mRNA, Plasmid, Oligonucleotide
Capacity assessment: 58.0/100
Sites: Seraing, Belgium
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Seraing, Belgium
Modalities: mRNA, Plasmid, Oligonucleotide
Capacity assessment: 58.0/100
Kaneka Eurogentec EMA GMP Compliance 4 certificates
2025-03
2024-02
2024-02
2024-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| BE/GMP/2025/009 | Kaneka Eurogentec | Belgium | 2025-03-13 | COMPLIANT |
| BE/GMP/2024/009 | Kaneka EurogentecAlternative Name:Kaneka Eurogentec S.A. | Belgium | 2024-02-26 | COMPLIANT |
| BE/GMP/2024/008 | Kaneka EurogentecAlternative Name:Kaneka Eurogentec S.A. | Belgium | 2024-02-26 | COMPLIANT |
| BE/GMP/2024/010 | Kaneka EurogentecAlternative Name:Kaneka Eurogentec S.A. | Belgium | 2024-02-26 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Jul 04, 2026
Frequently Asked Questions About Kaneka Eurogentec
Does Kaneka Eurogentec hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for Kaneka Eurogentec.
What is Kaneka Eurogentec's CDMO Signal Score?
Kaneka Eurogentec has a Signal Score of 80/100, based on quality, operations, financial stability, and capacity data.
Evaluating Kaneka Eurogentec for a manufacturing program?
Use the free AI matchmaker to compare Kaneka Eurogentec against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Aldevron
Fargo, ND
Signal Score: 85.3
Plasmid, mRNA
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Nitto Denko Avecia
Milford, MA
Signal Score: 80.3
Oligonucleotide, mRNA
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics